Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$306.88 - $380.0 $1.56 Million - $1.93 Million
-5,089 Reduced 79.92%
1,279 $484,000
Q3 2023

Nov 14, 2023

BUY
$315.92 - $397.36 $2.01 Million - $2.53 Million
6,368 New
6,368 $2.03 Million
Q3 2022

Nov 14, 2022

SELL
$263.81 - $337.27 $2.22 Million - $2.84 Million
-8,418 Reduced 51.25%
8,006 $2.11 Million
Q2 2022

Aug 15, 2022

BUY
$301.4 - $428.42 $4.95 Million - $7.04 Million
16,424 New
16,424 $5.14 Million
Q4 2021

Feb 14, 2022

SELL
$373.53 - $434.12 $238,312 - $276,968
-638 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$396.76 - $455.92 $253,132 - $290,876
638 New
638 $264,000
Q2 2021

Aug 16, 2021

SELL
$372.36 - $412.07 $962,922 - $1.07 Million
-2,586 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$357.26 - $392.57 $923,874 - $1.02 Million
2,586 New
2,586 $993,000
Q4 2020

Feb 16, 2021

SELL
$319.05 - $363.32 $416,679 - $474,495
-1,306 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$280.08 - $347.78 $2.68 Million - $3.32 Million
-9,552 Reduced 87.97%
1,306 $440,000
Q2 2020

Aug 17, 2020

BUY
$270.93 - $320.3 $2.45 Million - $2.9 Million
9,051 Added 500.89%
10,858 $3.08 Million
Q1 2020

May 15, 2020

BUY
$243.44 - $359.98 $439,896 - $650,483
1,807 New
1,807 $498,000
Q4 2019

Feb 14, 2020

SELL
$281.18 - $322.05 $245,751 - $281,471
-874 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$294.25 - $341.49 $257,174 - $298,462
874 New
874 $260,000
Q4 2018

Feb 14, 2019

SELL
$232.7 - $281.66 $174,525 - $211,245
-750 Closed
0 $0
Q3 2018

Nov 01, 2018

BUY
$236.3 - $277.15 $177,225 - $207,862
750 New
750 $208,000
Q4 2017

Feb 01, 2018

SELL
$217.88 - $244.43 $2.2 Million - $2.47 Million
-10,120 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$231.6 - $253.39 $2.34 Million - $2.56 Million
10,120
10,120 $2.4 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.